Venker Eric

SEC CIK
0001801917

Latest role at each company

Trades

Every Form 4 that lists Venker Eric as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
ROIVRoivant Sciences Ltd.Sep 1, 20269:00 PM ETAug 28, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$35.767−$7.15M1.6M−11.1%SEC10b5-1
ROIVRoivant Sciences Ltd.Jul 29, 20269:00 PM ETJul 27, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$34.95−$6.99M1.61M−11.0%SEC10b5-1
IMVTImmunovant, Inc.Jul 6, 20265:01 PM ETJul 2, 2026Venker EricChief Executive OfficerSSaleCommon Stock−3.09K$38.48−$118.98K254.28K−1.2%SEC
ROIVRoivant Sciences Ltd.Jun 26, 2026Jun 24, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$33.1563−$6.63M1.61M−11.0%SEC10b5-1
ROIVRoivant Sciences Ltd.May 22, 2026May 22, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$30.27−$6.05M1.61M−11.0%SEC10b5-1
ROIVRoivant Sciences Ltd.Apr 22, 2026Apr 20, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$29.59−$5.92M1.65M−10.8%SEC10b5-1
IMVTImmunovant, Inc.Apr 3, 2026Apr 2, 2026Venker EricChief Executive OfficerSSaleCommon Stock−14.23K$24.0955−$342.85K19.56K−42.1%SEC
ROIVRoivant Sciences Ltd.Mar 19, 2026Mar 17, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$28.24−$5.65M1.65M−10.8%SEC10b5-1
ROIVRoivant Sciences Ltd.Feb 18, 2026Feb 13, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$26.49−$5.3M1.65M−10.8%SEC10b5-1
ROIVRoivant Sciences Ltd.Jan 14, 2026Jan 12, 2026Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$21.92−$4.38M1.65M−10.8%SEC10b5-1
ROIVRoivant Sciences Ltd.Dec 29, 2025Dec 23 – Dec 24, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−275K$22.4718−$6.18M1.65M−14.3%SEC
ROIVRoivant Sciences Ltd.Dec 11, 2025Dec 9, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$20.85−$4.17M1.5M−11.8%SEC10b5-1
ROIVRoivant Sciences Ltd.Nov 7, 2025Nov 7, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−200K$20.22−$4.04M1.5M−11.7%SEC10b5-1
ROIVRoivant Sciences Ltd.Oct 17, 2025Oct 15 – Oct 17, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−851.38K$16.9929−$14.47M1.5M−36.1%SEC10b5-1
ROIVRoivant Sciences Ltd.Oct 14, 2025Oct 9 – Oct 13, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−125.67K$16.2918−$2.05M1.5M−7.7%SEC10b5-1
ROIVRoivant Sciences Ltd.Oct 8, 2025Oct 6 – Oct 8, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−665.16K$16.2094−$10.78M1.5M−30.7%SEC10b5-1
ROIVRoivant Sciences Ltd.Sep 23, 2025Sep 19 – Sep 23, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−1.71M$14.918−$25.52M1.5M−53.2%SEC10b5-1
ROIVRoivant Sciences Ltd.Aug 22, 2025Aug 20, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−100K$11.72−$1.17M1.65M−5.7%SEC10b5-1
ROIVRoivant Sciences Ltd.Jul 23, 2025Jul 21, 2025Venker EricPresident & Immunovant CEOSSaleCommon Shares−100K$11.52−$1.15M1.46M−6.4%SEC10b5-1
ROIVRoivant Sciences Ltd.Jun 24, 2025Jun 20, 2025Venker EricPresident & COOSSaleCommon Shares−100K$11.45−$1.15M1.46M−6.4%SEC10b5-1
ROIVRoivant Sciences Ltd.Jun 4, 2025Jun 2 – Jun 3, 2025Venker EricPresident & COOSSaleCommon Shares−1M$11.1549−$11.15M1.46M−40.6%SEC
ROIVRoivant Sciences Ltd.May 22, 2025May 20, 2025Venker EricPresident & COOSSaleCommon Shares−100K$10.95−$1.1M1.08M−8.5%SEC10b5-1
ROIVRoivant Sciences Ltd.Apr 22, 2025Apr 21, 2025Venker EricPresident & COOSSaleCommon Shares−100K$10.22−$1.02M1.12M−8.2%SEC10b5-1
ROIVRoivant Sciences Ltd.Mar 24, 2025Mar 20 – Mar 24, 2025Venker EricPresident & COOSSaleCommon Shares−750K$10.921−$8.19M1.13M−40.0%SEC10b5-1
ROIVRoivant Sciences Ltd.Feb 24, 2025Feb 20, 2025Venker EricPresident & COOSSaleCommon Shares−100K$10.65−$1.07M896.87K−10.0%SEC
ROIVRoivant Sciences Ltd.Feb 14, 2025Feb 12 – Feb 13, 2025Venker EricPresident & COOSSaleCommon Shares−435.43K$10.4749−$4.56M896.87K−32.7%SEC
ROIVRoivant Sciences Ltd.Jan 22, 2025Jan 21, 2025Venker EricPresident & COOSSaleCommon Shares−100K$11.28−$1.13M732.29K−12.0%SEC10b5-1
ROIVRoivant Sciences Ltd.Dec 31, 2024Dec 27 – Dec 30, 2024Venker EricPresident & COOSSaleCommon Shares−354.6K$11.6797−$4.14M740.98K−32.4%SEC
ROIVRoivant Sciences Ltd.Dec 26, 2024Dec 20, 2024Venker EricPresident & COOSSaleCommon Shares−100K$11.49−$1.15M595.58K−14.4%SEC10b5-1
ROIVRoivant Sciences Ltd.Nov 22, 2024Nov 20, 2024Venker EricPresident & COOSSaleCommon Shares−100K$11.32−$1.13M606.53K−14.2%SEC10b5-1
ROIVRoivant Sciences Ltd.Oct 22, 2024Oct 21, 2024Venker EricPresident & COOSSaleCommon Shares−100K$11.65−$1.17M617.47K−13.9%SEC
ROIVRoivant Sciences Ltd.Feb 9, 2024Feb 9, 2024Venker EricPresident & COOSSaleCommon Shares−96.95K$10.92−$1.06M532.21K−15.4%SEC10b5-1
ROIVRoivant Sciences Ltd.Oct 4, 2023Oct 2 – Oct 5, 2023Venker EricChief Operating OfficerSSaleCommon Shares−1.2M$10.4342−$12.52M595.4K−66.8%SEC10b5-1
ROIVRoivant Sciences Ltd.Sep 29, 2023Sep 27, 2023Venker EricPresident & COOSSaleCommon Shares−500K$13.02−$6.51M595.4K−45.6%SEC
ROIVRoivant Sciences Ltd.Sep 12, 2023Sep 8, 2023Venker EricChief Operating OfficerSSaleCommon Shares−106.43K$12.19−$1.3M611.81K−14.8%SEC
ROIVRoivant Sciences Ltd.Sep 6, 2023Sep 1 – Sep 6, 2023Venker EricChief Operating OfficerSSaleCommon Shares−93.96K$11.9124−$1.12M611.81K−13.3%SEC
ROIVRoivant Sciences Ltd.Aug 16, 2023Aug 14, 2023Venker EricChief Operating OfficerSSaleCommon Shares−59.81K$11.89−$711.15K627.92K−8.7%SEC
ROIVRoivant Sciences Ltd.Aug 7, 2023Aug 3, 2023Venker EricChief Operating OfficerSSaleCommon Shares−44.63K$11.93−$532.42K627.92K−6.6%SEC
ROIVRoivant Sciences Ltd.Aug 2, 2023Jul 31 – Aug 2, 2023Venker EricChief Operating OfficerSSaleCommon Shares−195.17K$11.9089−$2.32M627.92K−23.7%SEC
ROIVRoivant Sciences Ltd.Jul 27, 2023Jul 25 – Jul 27, 2023Venker EricChief Operating OfficerSSaleCommon Shares−125.53K$10.9119−$1.37M627.92K−16.7%SEC
ROIVRoivant Sciences Ltd.Jul 24, 2023Jul 20 – Jul 24, 2023Venker EricPresident & COOSSaleCommon Shares−374.47K$11.1889−$4.19M644.22K−36.8%SEC
ROIVRoivant Sciences Ltd.Jun 9, 2023Jun 7 – Jun 9, 2023Venker EricPresident & COOSSaleCommon Shares−299.59K$9.91−$2.97M660.1K−31.2%SEC
ROIVRoivant Sciences Ltd.May 25, 2023May 23, 2023Venker EricPresident & COOSSaleCommon Shares−415$9.85−$4.09K675.77K−0.1%SEC
ROIVRoivant Sciences Ltd.May 11, 2023May 9, 2023Venker EricPresident & COOSSaleCommon Shares−238.72K$9.23−$2.2M675.77K−26.1%SEC
ROIVRoivant Sciences Ltd.May 8, 2023May 4 – May 8, 2023Venker EricPresident & COOSSaleCommon Shares−150.04K$8.557−$1.28M675.77K−18.2%SEC10b5-1
ROIVRoivant Sciences Ltd.May 3, 2023May 1 – May 3, 2023Venker EricPresident & COOSSaleCommon Shares−288.99K$8.3987−$2.43M675.77K−30.0%SEC10b5-1
ROIVRoivant Sciences Ltd.Apr 28, 2023Apr 26 – Apr 28, 2023Venker EricPresident & COOSSaleCommon Shares−222.24K$8.5456−$1.9M675.77K−24.7%SEC10b5-1
ROIVRoivant Sciences Ltd.Jan 6, 2023Jan 5, 2023Venker EricPresident & COOSSaleCommon Shares−24.04K$8.02−$192.78K729.43K−3.2%SEC
ROIVRoivant Sciences Ltd.Jan 4, 2023Dec 30, 2022 – Jan 3, 2023Venker EricPresident & COOSSaleCommon Shares−119.25K$7.4555−$889.03K753.47K−13.7%SEC
ROIVRoivant Sciences Ltd.Dec 9, 2022Dec 8 – Dec 9, 2022Venker EricPresident & COOSSaleCommon Shares−145.11K$7.0276−$1.02M888.74K−14.0%SEC